CD56+ CD3− NK cells were found in higher frequencies among circulating vs. tumor-infiltrating leukocytes (mean 9.37 vs. 0.63% among PBMC and TIL, respectively; Figure 10A). This evidence concerns the gene NCAM1 and neoplasm.